missing translation for 'onlineSavingsMsg'
Learn More
Learn More
FLT4 Polyclonal Antibody, Invitrogen™
Rabbit Polyclonal Antibody
Brand: Invitrogen PA5109730
Additional Details : Weight : 0.01000kg
Description
Immunogen sequence: YYNWVSFPGC LARGAETRGS SRMKTFEEFP MTPTTYKGSV DNQTDSGMVL ASEEFEQIES RHRQESGFSC KGPGQNVAVT RAHPDSQGRR RRPERGARGG
Vascular endothelial growth factor is a key regulator of blood vessel development in embryos and angiogenesis in adult tissues. Unlike VEGF, the related VEGFC stimulates the growth of lymphatic vessels through its specificl ymphatic endothelial receptor VEGFR-3. In 1998, Dumont showed that targeted inactivation of the VEGFR-3 gene in mice resulted in defective blood vessel development in early embryos. Vasculogenesis and angiogenesis occurred, but large vessels became abnormally organized with defective lumens, leading to fluid accumulation in the pericardial cavity and cardiovascular failure at embryonic day 9.5. Thus, VEGFR3 has an essential role in the development of theembryonic cardiovascular system before the emergence of the lymphatic vessels.Specifications
FLT4 | |
Polyclonal | |
Unconjugated | |
FLT4 | |
AI323512; Chy; chylous ascites; Flt4; FLT-4; FLT41; fms related tyrosine kinase 4; FMS-like tyrosine kinase 4; fms-related tyrosine kinase 4; LMPH1A; PCL; receptor protein tyrosine kinase; soluble VEGFR 3; sVEGFR 3; tyrosine-protein kinase receptor FLT4; Vascular endothelial growth factor receptor 3; vascular endothelial growth factor receptor-3; VEGF R3; VEGFR3; VEGFR-3 | |
Rabbit | |
Affinity Chromatography | |
RUO | |
2324 | |
-20° C, Avoid Freeze/Thaw Cycles | |
Liquid |
Western Blot | |
0.4 mg/mL | |
PBS with 50% glycerol and 0.01% thimerosal; pH 7.3 | |
P35916 | |
FLT4 | |
A synthetic peptide corresponding to a sequence within amino acids 1230-1329 of human VEGFR3/FLT4 (NP_8915552) | |
100 μL | |
Primary | |
Human | |
Antibody | |
IgG |